Business & Finance
Sanofi Lines Up Takeover Target to Fix Pharma’s Lowest Valuation
Key Points
Sanofi Lines Up Takeover Target to Fix Pharma’s Lowest Valuation To understand why Sanofi is pursuing what would be the biggest takeover in the pharmaceutical industry in years, look no further than one number. Even after a surge since early October, the stock trades at 9 times estimated earnings, making Sanofi the cheapest among the world’s 10 biggest pharmaceutical companies by sales. The multiple is below the group average of 17.3.
Sanofi Lines Up Takeover Target to Fix Pharma’s Lowest Valuation
To understand why Sanofi is pursuing what would be the biggest takeover in the pharmaceutical industry in years, look no further than one number.
Even after a surge since early October, the stock trades at 9 times estimated earnings, making Sanofi the cheapest among the world’s 10 biggest pharmaceutical companies by sales. The multiple is below the group average of 17.3. The stock is underperforming many of its big rivals this year.